MRC1 and neoplasm: The primary approach to identifying individuals with Lynch Syndrome (LS) typically involves analyzing colorectal and endometrial cancer tumor samples for microsatellite instability (MSI) or deficiencies in mismatch repair (MMR) protein expression, followed by confirmatory germline testing for those with indicative tumor test results.